Effect of treatment with original or biosimilar adalimumab on SARS-CoV2 vaccination antibody titers
Description
The technological process of production of biosimilars determines the degree of biosimilarity to the original biological drug. In particular, the focus is on the similarity of immunogenic responses. The primary endpoint of our retrospective study was
